TCL Archive Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial April 27, 2012
TCL Archive Trastuzumab Showed Improved Survival In Stage IV Breast Cancer with CNS Metastases August 26, 2011